Abstract:Background: The spread of infectious diseases in populations is controlled by the susceptibility (propensity to acquire infection), infectivity (propensity to transmit infection), and recoverability (propensity to recover/die) of individuals. Estimating genetic risk factors for these three underlying host epidemiological traits can help reduce disease spread through genetic control strategies. Previous studies have identified important 'disease resistance single nucleotide polymorphisms (SNPs)', but how these affect the underlying traits is an unresolved question. Recent advances in computational statistics make it now possible to estimate the effects of SNPs on host traits from epidemic data (e.g. infection and/or recovery times of individuals or diagnostic test results). However, little is known about how to effectively design disease transmission experiments or field studies to maximise the precision with which these effects can be estimated. Results: In this paper, we develop and validate analytical expressions for the precision of the estimates of SNP effects on the three above host traits for a disease transmission experiment with one or more non-interacting contact groups. Maximising these expressions leads to three distinct 'experimental' designs, each specifying a different set of ideal SNP genotype compositions across groups: (a) appropriate for a single contact-group, (b) a multi-group design termed "pure", and (c) a multi-group design termed "mixed", where 'pure' and 'mixed' refer to groupings that consist of individuals with uniformly the same or different SNP genotypes, respectively. Precision estimates for susceptibility and recoverability were found to be less sensitive to the experimental design than estimates for infectivity. Whereas the analytical expressions suggest that the multi-group pure and mixed designs estimate SNP effects with similar precision, the mixed design is preferred because it uses information from naturally-occurring rather than artificial infections. The same design principles apply to estimates of the epidemiological impact of other categorical fixed effects, such as breed, line, family, sex, or vaccination status. Estimation of SNP effect precisions from a given experimental setup is implemented in an online software tool SIRE-PC. Conclusions: Methodology was developed to aid the design of disease transmission experiments for estimating the effect of individual SNPs and other categorical variables that underlie host susceptibility, infectivity and recoverability. Designs that maximize the precision of estimates were derived.

Use of the test-negative design to estimate the protective effect of a scalar immune measure: A simulation analysis

Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness

Potential Biases in Test-Negative Design Studies of COVID-19 Vaccine Effectiveness Arising from the Inclusion of Asymptomatic Individuals

Inference of Naturally Acquired Immunity Using a Self-matched Negative-Control Design

An analytic approach for understanding mechanisms driving breakthrough infections

TNDDR: Efficient and doubly robust estimation of COVID-19 vaccine effectiveness under the test-negative design

Improved Methods for Vaccine Effectiveness Studies

Sensitivity Analysis for the Test-Negative Design

Estimating Waning of Vaccine Effectiveness: a Simulation Study

Severity-dependent test-seeking behaviors and test-negative designs: impact on estimated vaccine effectiveness and utility of analytic and design choices

Optimal experimental designs for estimating genetic and non-genetic effects underlying infectious disease transmission

A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness under the Test-Negative Design: Analysis of Quebec Administrative Data

Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review

Test-negative Design:Basic Principles,Methods of Implementation,Types of Derivatives,Advantages, Limitations,and Applications

Adjustment for Disease Severity in the Test-Negative Study Design

Simulation and inference on purely observational methods of monitoring vaccine effectiveness post-deployment: none is reliable without precise information on population behaviour

Test-negative designs with various reasons for testing: statistical bias and solution

Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19

Impact of unequal testing on vaccine effectiveness estimates across two study designs: a simulation study

Beyond Vaccination Rates: A Synthetic Random Proxy Metric of Total SARS-CoV-2 Immunity Seroprevalence in the Community